Page 1 of Clinical Trials for "Fenretinide", 40 Total Matches
- 1TerminatedLast Updated: October 22, 2010Condition(s): Head and Neck Cancer
- 2Not yet recruitingLast Updated: March 9, 2012Condition(s): Solid Tumor
- 3RecruitingLast Updated: February 16, 2012Condition(s): Ovarian Cancer; Cancer of Ovary; Cancer of the Ovary; Ovary Neoplasms; Primary Peritoneal Carcinoma
- 4CompletedLast Updated: August 5, 2010Condition(s): Cervical Cancer; Precancerous Condition
- 5CompletedLast Updated: August 5, 2010Condition(s): Breast Cancer
- 6RecruitingLast Updated: February 3, 2012Condition(s): Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Non-Hodgkin's Lymphoma
- 7CompletedLast Updated: July 23, 2010Condition(s): Head and Neck Cancer
- 8CompletedLast Updated: June 21, 2010Condition(s): Geographic Atrophy; Dry Age Related Macular Degeneration
- 9RecruitingLast Updated: November 24, 2011Condition(s): High-Risk Cancer
- 10RecruitingLast Updated: February 16, 2012Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 11CompletedLast Updated: June 9, 2010Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 12CompletedLast Updated: February 6, 2009Condition(s): Brain and Central Nervous System Tumors
- 13TerminatedLast Updated: July 28, 2011Condition(s): Head and Neck Cancer
- 14RecruitingA Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With ObesityLast Updated: March 3, 2011Condition(s): Obesity; Insulin Resistance
- 15CompletedLast Updated: July 23, 2008Condition(s): Bladder Cancer
- 16Active, not recruitingLast Updated: February 16, 2012Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
- 17CompletedLast Updated: March 7, 2012Condition(s): Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
- 18CompletedLast Updated: October 11, 2010Condition(s): Prostate Cancer
- 19Active, not recruitingLast Updated: May 30, 2009Condition(s): Head and Neck Cancer
- 20TerminatedLast Updated: March 8, 2009Condition(s): Ovarian Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Fenretinide%22
